| Mineral Point Health Services | |
| 109 N Iowa St, Mineral Point, Wisconsin 53565 | |
| (608) 987-2381 | |
| Name | Mineral Point Health Services |
|---|---|
| Location | 109 N Iowa St, Mineral Point, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 30 |
| Occupancy Rate | 84% |
| Medicare ID (CCN) | 525354 |
| Legal Business Name | Nsh Mineral Point Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1073506218 |
| Organization Name | MINERAL POINT CARE CENTER LLC |
| Doing Business As | D/B/A ATRIUM POST ACUTE CARE OF MINERAL POINT |
| Address | 109 N Iowa St, Mineral Point, WI 53565 |
| Phone Number | 608-987-2381 |
News Archive
An internal transporter that enables us to use the copper we consume in foods like shellfish and nuts to enable a host of vital body functions also has the essential role of protecting the receptor that enables us to grow new blood vessels when ours become diseased, Medical College of Georgia scientists report.
Experts estimate up to one third of people attending specialist memory clinics could have a condition that is commonly mistaken for early dementia.
Sucampo Pharmaceuticals, Inc. today announced the presentation of results from a phase 3 clinical trial investigating the use of lubiprostone in non-cancer pain patients with Opioid-induced Bowel Dysfunction (OBD). These results were the subject of an oral presentation at the Digestive Disease Week (DDW) 2010 conference in New Orleans, Louisiana, on May 5, 2010.
PLOS, the Public Library of Science, today is launching the Accelerating Science Award Program that recognizes the use of scientific research, published through Open Access, which has led to innovations in any field that benefit society. Major sponsors include the Wellcome Trust and Google.
› Verified 7 days ago
| NPI Number | 1134762073 |
| Organization Name | NSH MINERAL POINT LLC |
| Address | 109 N Iowa St, Mineral Point, WI 53565 |
| Phone Number | 608-987-2381 |
News Archive
An internal transporter that enables us to use the copper we consume in foods like shellfish and nuts to enable a host of vital body functions also has the essential role of protecting the receptor that enables us to grow new blood vessels when ours become diseased, Medical College of Georgia scientists report.
Experts estimate up to one third of people attending specialist memory clinics could have a condition that is commonly mistaken for early dementia.
Sucampo Pharmaceuticals, Inc. today announced the presentation of results from a phase 3 clinical trial investigating the use of lubiprostone in non-cancer pain patients with Opioid-induced Bowel Dysfunction (OBD). These results were the subject of an oral presentation at the Digestive Disease Week (DDW) 2010 conference in New Orleans, Louisiana, on May 5, 2010.
PLOS, the Public Library of Science, today is launching the Accelerating Science Award Program that recognizes the use of scientific research, published through Open Access, which has led to innovations in any field that benefit society. Major sponsors include the Wellcome Trust and Google.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
An internal transporter that enables us to use the copper we consume in foods like shellfish and nuts to enable a host of vital body functions also has the essential role of protecting the receptor that enables us to grow new blood vessels when ours become diseased, Medical College of Georgia scientists report.
Experts estimate up to one third of people attending specialist memory clinics could have a condition that is commonly mistaken for early dementia.
Sucampo Pharmaceuticals, Inc. today announced the presentation of results from a phase 3 clinical trial investigating the use of lubiprostone in non-cancer pain patients with Opioid-induced Bowel Dysfunction (OBD). These results were the subject of an oral presentation at the Digestive Disease Week (DDW) 2010 conference in New Orleans, Louisiana, on May 5, 2010.
PLOS, the Public Library of Science, today is launching the Accelerating Science Award Program that recognizes the use of scientific research, published through Open Access, which has led to innovations in any field that benefit society. Major sponsors include the Wellcome Trust and Google.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.71 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.14 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.16 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.36 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.23 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.3 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.21 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 97.89 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.77 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.95 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 4.08 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 15.05 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.52 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 2.78 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.03 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 55.09 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.41 | 82.93 |
News Archive
An internal transporter that enables us to use the copper we consume in foods like shellfish and nuts to enable a host of vital body functions also has the essential role of protecting the receptor that enables us to grow new blood vessels when ours become diseased, Medical College of Georgia scientists report.
Experts estimate up to one third of people attending specialist memory clinics could have a condition that is commonly mistaken for early dementia.
Sucampo Pharmaceuticals, Inc. today announced the presentation of results from a phase 3 clinical trial investigating the use of lubiprostone in non-cancer pain patients with Opioid-induced Bowel Dysfunction (OBD). These results were the subject of an oral presentation at the Digestive Disease Week (DDW) 2010 conference in New Orleans, Louisiana, on May 5, 2010.
PLOS, the Public Library of Science, today is launching the Accelerating Science Award Program that recognizes the use of scientific research, published through Open Access, which has led to innovations in any field that benefit society. Major sponsors include the Wellcome Trust and Google.
› Verified 7 days ago
Mineral Point Health Services Location: 109 N Iowa St, Mineral Point, Wisconsin 53565 Phone: (608) 987-2381 |